Company Filing History:

7 out of 1,997

The State University of New York

patents

1 out of 3

Research Foundation of State of N.y.

where one patent can have more than one assignee

Years Active: 1984-1993

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5192764 - Pyrazinone N-oxide nucleosides and analogs thereof (1993-03-09),

2. 4895937 - 5-ioso-2-pyrimidinone nucleoside (1990-01-23),

3. 4886790 - Novel bis(2,2-dimethyl-1-aziridinyl) phosphinic amides for use in the (1989-12-12),

4. 4882147 - Novel polynucleotide analogs, methods for inhibiting nucleic acid (1989-11-21),

5. 4782142 - Novel 5-substituted 2-pyrimidinone nucleosides and methods of use (1988-11-01),

6. 4617398 - Phosphoaziridine compounds useful for treatment of tumors (1986-10-14),

7. 4544501 - Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the treatment (1985-10-01),

8. 4468384 - Method for the inhibition of the replication of DNA viruses with (1984-08-28),

Title: The Innovative Contributions of Thomas J Bardos

Introduction

Thomas J Bardos is a notable inventor based in Snyder, NY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, Bardos has focused on developing compounds that address various medical conditions, particularly those related to viral and microbial infections.

Latest Patents

Among his latest patents, Bardos has developed the "Pyrazinone N-oxide nucleosides and analogs thereof." This invention pertains to nucleoside and acyclo analogs that contain 5- or 6-substituted 2-pyrazinone-4-N-oxide. These compounds are particularly useful for treating a range of conditions, including viral infections, cancer, fungal infections, bacterial infections, and other related disease states. Additionally, this invention encompasses pharmaceutical formulations that incorporate these compounds, as well as methods for treating the aforementioned conditions in both animals and humans. Another significant patent is the "5-ioso-2-pyrimidinone nucleoside," which features the nucleoside 1-(2-Deoxy-.beta.-D-ribofuranosyl)-5-(iodo)-2-pyrimidinone. This compound exhibits a high level of antiviral activity while maintaining a low level of toxicity to host cells, making it an effective therapeutic agent for HSV-2.

Career Highlights

Bardos has had a distinguished career, working with prominent institutions such as the State University of New York and the Research Foundation of State of New York. His work has significantly advanced the understanding and treatment of various infectious diseases.

Collaborations

Throughout his career, Bardos has collaborated with esteemed colleagues, including Yung-Chi Cheng and Alan C Schroeder. These partnerships have contributed to the development of innovative solutions in the pharmaceutical field.

Conclusion

Thomas J Bardos stands out as a prolific inventor whose work has made a meaningful impact on medical science. His patents reflect a commitment to addressing critical health challenges through innovative pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com